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Abstract A novel mouse cysteine protease of the papain family
was identified by searching the dbEST database. A 1.28 kb full-
length cDNA was obtained which contains an open reading frame
of 999 nucleotides and encodes a predicted polypeptide of 333
amino acids. The deduced polypeptide exhibits features char-
acteristic of cysteine proteases of the papain type including the
highly conserved residues of the catalytic triad, and was hence
named cathepsin J. Cathepsin J represents the murine homologue
of a previously described rat cathepsin L-related protein. Mature
cathepsin J shows 59.3% identity to mouse cathepsin L and
contains the characteristic ER(F/W)NIN motif within the
propeptide indicating that this protease belongs to the subgroup
of cathepsin L-like cysteine proteases. Northern blot analysis of
various tissues revealed a placenta-restricted expression. This
expression pattern may suggest a role of cathepsin J in embryo
implantation and/or placental function. Ctsj was mapped to
mouse chromosome 13 in the vicinity of cathepsin L suggesting
that cathepsin J may have arisen by gene duplication from
cathepsin L or a common ancestral gene.
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1. Introduction
The C1 family of papain-like cysteine peptidases represents
a major component of the endosomal/lysosomal proteolytic
system. All members of the C1 family share the characteristic
catalytic residues Cys25, His159 and Asn175 (numbering accord-
ing to mature papain) forming a ‘catalytic triad’. To date 11
members of the C1 family have been identi¢ed and character-
ized at the molecular level in human and mouse ([1^5], http://
www.bi.bbsrc.ac.uk/Merops/Merops.htm). The C1 proteases
of mammals can be subdivided into two functional groups
according to their respective tissue distribution. The ¢rst
group exhibits ubiquitous expression and comprises the highly
abundant cathepsins B, H and L [6^8] as well as the recently
discovered cathepsins C, O, F and Z [9^12]. These ubiqui-
tously expressed proteases are believed to play an essential
role in unspeci¢c terminal protein degradation [13]. Addition-
al more speci¢c functions in physiological and pathophysio-
logical processes such as prohormone processing [14], antigen
presentation [15], rheumatoid arthritis [16], pulmonary em-
physema [17], cancer invasion and metastasis [18], muscular
dystrophy [19] and Alzheimer’s disease [20] have been postu-
lated. Recently it has been shown that cathepsin L is necessary
for processing of the invariant chain (Ii) of major histocom-
patibility complex class II molecules in cortical thymic epithe-
lial cells and thus for positive selection of CD4 T-lympho-
cytes [21]. Furthermore, cathepsin L was shown to be essential
for regulation of proliferation of basal keratinocytes and hair
follicle epithelial cells [22].
The members of the second functional group of C1 pro-
teases comprising cathepsins K, L2, S and W [23^26] exhibit
a tissue-restricted expression pattern. Cathepsin K is highly
expressed in osteoclasts and is a major player in bone resorp-
tion [27]. Mutations in the human cathepsin K gene are the
molecular basis of pycnodysostosis, an autosomal recessive
osteochondrodysplasia [28]. Cathepsin S is expressed in lym-
phatic tissues and is essential for the degradation of Ii in
peripheral antigen presenting cells [29,30]. Furthermore, a
role of cathepsin S in macrophage-mediated tissue destruction
has been postulated [25]. Cathepsin L2 [24], which is highly
related to cathepsin L, is expressed in thymus and testis,
whereas cathepsin W is predominantly expressed in CD8
T-lymphocytes [26].
The ¢rst four mammalian C1 proteases, cathepsin B, H, L
and S [31^34], were discovered with conventional biochemical
techniques. The enzyme activities were puri¢ed from tissues
and characterized by standard enzymological approaches. In-
creasing numbers of entries in expressed sequence tag (EST)
databases accelerated the identi¢cation of novel C1 proteases
considerably [11,12,24,26,35].
Here we describe the identi¢cation of a novel murine C1
protease, named cathepsin J (CTSJ), its expression pattern
and the chromosomal localization of the cathepsin J gene.
2. Materials and methods
2.1. Identi¢cation and sequencing of cathepsin J cDNAs
A dbEST database [36] search for novel C1 proteases using an
alignment of the C1 protease family [4] as a search matrix was per-
formed with SearchWise [37] at the Abteilung Theoretische Bioinfor-
matik, DKFZ, Heidelberg. Identi¢ed mouse ESTs were aligned using
GelStart, GelEnter, GelMerge and GelView from the Heidelberg Unix
Sequence Analysis Resources (HUSAR). Resulting contigs were
aligned with all known human and murine C1 proteases. Contigs
representing known C1 proteases were discarded. Remaining contigs
were searched for the presence of motifs speci¢c for C1 proteases [4].
ESTs of contigs resembling putative novel cysteine proteases were
obtained from the Resource Center of the German Human Genome
Project (DHGP), Berlin. Here we report analysis of contig J contain-
ing ESTs: J1 (AA096626, IMAGp998L121330) and J2 (AA013726,
IMAGp998C171042). Both strands of the two ESTs were sequenced
using an Applied Biosystems model 377 DNA sequencer. Sequences
were assembled and analyzed using DNASTAR 1.3 (DNASTAR
Inc.). Multiple sequence alignments with previously described mouse
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Fig. 1. Nucleotide sequence and predicted amino acid sequence of murine cathepsin J cDNA. The amino acid sequence is shown in single-letter
code below the nucleotide sequence. The active site residues Cys137, His275 and Asn299 of the ‘catalytic triad’ characteristic for the C1 family of
cysteine proteases [4] are shown in black boxes. Potential N-glycosylation sites are underlined, arrowheads indicate the putative cleavage sites
between the signal sequence and the propeptide as well as between the propeptide and the mature enzyme. Conserved amino acids in the prore-
gion forming the ER(F/W)NIN motif are given in bold lettering. The putative polyadenylation signal is indicated in bold and underlined. The
extension of the ESTs is enclosed in arrows with respective accession number.
C
Fig. 2. Multiple protein alignment of murine cathepsin J with rat cathepsin-related protein and mouse cathepsins B, C, F, H, K, L, S, W, and
Z. The amino acid sequences of previously described rat or murine C1 cysteine proteases were extracted from SwissProt and GenBank data-
bases (accession numbers: rat cathepsin L related protein (rCLRP), L14776; mouse cathepsin B (mCTSB), P10605; mouse cathepsin C
(mCTSC), P97821; mouse cathepsin H (mCTSH), P49935; mouse cathepsin K (mCTSK), P55097; mouse cathepsin L (mCTSL), P06797;
mouse cathepsin S (mCTSS), AF038546; mouse cathepsin W (mCTSW), P56203; mouse cathepsin F (mCTSF), AF136280; mouse cathepsin Z
(mCTSZ), AF136277. Multiple sequence alignment of mature proteases was performed with CLUSTAL X [37]. Active site residues are indi-
cated by an asterisk. Conserved residues which are common to all sequences are shadowed, residues which are conserved in v70% of the se-
quences are in bold.
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C1 proteases were performed with CLUSTAL X [38] and homologies
were calculated with Gap (HUSAR). The nucleotide sequence of
mouse cathepsin J was submitted to GenBank (accession number:
AF136272).
2.2. Northern blot analysis
Total RNA of various tissues from 8 week old mice and of placenta
from mice at day 18 of gestation was prepared as described [39]. Total
RNA of blood was isolated using the QIAamp RNA Blood Mini Kit
(Qiagen) according to the recommendations of the manufacturer.
RNA was separated in a 1% formaldehyde agarose gel, transferred
to Hybond-N membrane (Amersham) and hybridized with an
[K-32P]dCTP-labeled full-length CTSJ cDNA as described [39]. Filters
were washed at high stringency as described [40]. Membranes were
stripped by boiling in 0.1% SDS for 10 min and rehybridized with a
540 bp cDNA fragment of murine L-actin [41].
2.3. Chromosomal localization
Mapping of Ctsj using an interspeci¢c backcross panel between
C57BL/6J and Mus spretus (BSS) was performed as described [40].
Brie£y, a XbaI restriction fragment length polymorphism (RFLP) was
identi¢ed by Southern blot analysis of genomic DNA from Mus mus-
culus C57BL/6J and M. spretus digested with multiple restriction en-
donucleases (New England Biolabs) and probed with the full-length
CTSJ cDNA. For mapping of Ctsj a mouse interspeci¢c backcross
panel derived from 94 N2 animals of the backcross [(C57BL/
6JEiUSPRET/Ei)F1USPRET/Ei] (BSS) was used [42]. Southern
blot ¢lters of this panel digested with XbaI were purchased from
The Jackson Laboratory. The presence or absence of C57BL/6J-spe-
ci¢c XbaI fragments was followed in the panel. Calculations of results
was performed at The Jackson Laboratory.
3. Results and discussion
3.1. Mouse cathepsin J cDNA
For identi¢cation of novel members of the C1 family of
papain-like cysteine proteases, a dbEST database [36] search
using an alignment of cysteine proteases [4] as search matrix
was performed. Two overlapping murine ESTs (AA096626
and AA013726), potentially encoding the conserved active
site sequence motifs of C1 proteases but di¡ering from all
previously described murine C1 proteases, were identi¢ed. Se-
quence analysis of these two ESTs revealed that EST
AA096626 is a full-length cDNA of 1276 nucleotides, whereas
the 5P end of EST AA013726 is located at nucleotide 327 and
its 3P end extends six nucleotides 3P of AA096626 (Fig. 1). The
nucleotide sequence depicted in Fig. 1 exhibits one long open
reading frame (ORF) of 999 nucleotides starting at nucleotide
82 with the putative initiator ATG codon and ending with a
stop codon at position 1081. The ORF potentially encodes a
polypeptide of 333 amino acids with a predicted molecular
weight of 37.2 kDa. This putative C1 protease was tentatively
named cathepsin J (CTSJ). The initiator ATG codon lacks a
typical Kozak consensus sequence [43] but three nucleotides 5P
of the initiator codon a characteristic and highly conserved
nucleotide A is present. The stop codon is followed by a 199
nucleotide 3P untranslated region which contains a putative
polyadenylation signal (ATTAAA) at position 1254, which
parallels the position of the polyadenylation signal of the
previously described rat homologue of CTSJ [44]. A poly(A)
tract not depicted in Fig. 1 was identi¢ed in both ESTs. CTSJ
contains a putative signal sequence of 17 amino acids accord-
ing to the 33, 31 rule for signal sequence cleavage sites [45].
The putative proregion of CTSJ consists of 95 amino acids.
The potential processing site between proregion and mature
enzyme has been assigned to the Gly112-Leu113 peptide bond
followed by a proline residue, which is typical for cysteine
proteases of the C1 family [4]. Mature CTSJ comprises 221
amino acids. CTSJ contains ¢ve putative N-glycosylation sites
at positions 71, 156, 216, 220 and 266 (Fig. 1). The presence
of a signal sequence and potential glycosylation sites may
suggest targeting of CTSJ to the endosomal/lysosomal com-
partment by mannose 6-phosphate receptors.
3.2. Sequence similarities to other murine cysteine proteases
At present eight murine cathepsins of the C1 family have
been characterized at the molecular level : cathepsins B, C, F,
H, K, L, S, and Z. A multiple sequence alignment of the
mature forms of these proteases with CTSJ clearly suggests
that CTSJ is a novel member of the papain-like C1 family of
cysteine proteases (Fig. 2). All highly conserved sequence mo-
tifs characteristic of C1 proteases have been identi¢ed, includ-
ing residues Cys137, His275 and Asn299 forming the ‘catalytic
triad’ (Fig. 2 [4]). CTSJ shares the highest identity at the
amino acid level (85%) with the previously described rat cathep-
sin L-related protein (rCLRP [44]) which was deduced from a
partial cDNA. This would indicate that CTSJ and rCLRP
resemble homologous proteins of di¡erent species. Alignment
of mouse CTSJ and rCLRP demonstrates a high degree of
Fig. 3. Northern blot analysis of murine cathepsin J in di¡erent
mouse tissues. Total RNA (8 Wg) from various organs was hybrid-
ized to the [K-32P]dCTP-labelled full-length CTSJ cDNA. Filters
were rehybridized after stripping with a 540 bp cDNA fragment
from murine L-actin [41].
Table 1
Sequence comparison of murine cathepsin J with murine cathepsins L, S, K, H, F, W, C, Z and Ba
Percent identity and similarity to murine cathepsin J
mCTSL mCTSS mCTSK mCTSH mCTSF mCTSW mCTSC mCTSZ mCTSB
Prepro-enzyme 52.9 (58.9) 47.5 (54.6) 45.5 (55.1) 37.9 (45.7) 36.1 (45.0) 31.3 (39.9) 29.7 (34.9) 29.7 (38.1) 28.8 (36.0)
Mature enzyme 59.3 (65.6) 55.8 (62.3) 52.3 (61.7) 45.6 (54.0) 41.1 (50.5) 34.6 (44.2) 39.5 (44.6) 34.6 (43.1) 32.4 (39.0)
aSequence identities and similarities (in parentheses) were calculated with the program Gap (HUSAR) using the Needleman and Wunsch algo-
rithm [56].
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homology throughout the whole amino acid sequence (Fig. 2).
The only region with striking mismatches is located between
residues Cys56 and Ser67 (Fig. 2). In contrast to all other
known C1 proteases ^ including CTSJ ^ rCLRP lacks the
cysteine residues Cys56 and Cys65 (Fig. 2 [4]). Among mouse
C1 proteases CTSJ shares the highest identity with CTSL
(Table 1). Furthermore, the proregion of CTSJ contains an
ER(F/W)NIN motif (Fig. 1) characteristic of the subgroup of
cathepsin L-like C1 proteases [46]. BLAST searches of the
human subset of the dbEST database with the murine CTSJ
cDNA as query sequence did not identify a human homo-
logue of CTSJ, bringing the existence of a human CTSJ ho-
mologue into question.
3.3. Tissue distribution of mouse cathepsin J
Northern blot analysis of RNA from multiple organs em-
ploying the full-length CTSJ cDNA as a probe showed that
CTSJ expression is restricted to the placenta only. This cor-
responds to the previously described expression pattern of
rCLRP. rCLRP was found to be highly expressed in placenta
during late gestation but not in liver or kidney [44]. The ap-
proximate size of the CTSJ mRNA was found to be 1.7 kb
(Fig. 3). This tissue-speci¢c expression of CTSJ in the placenta
may suggest a role of this protease in embryo implantation
and/or placental development and function. Both embryo im-
plantation and anchoring of the placenta in the uterine wall
require controlled invasion of the uterine stroma by embry-
onic trophoblasts. This invasion is known to be dependent
upon secretion of serine and matrix metalloproteinases, which
degrade the extracellular matrix of the uterine wall [47]. In
vitro trophoblast invasion has been inhibited by cysteine pro-
tease inhibitors suggesting that cysteine proteinases may also
play an important role in embryo implantation [48].
3.4. Mouse Ctsj maps to chromosome 13
The chromosomal localization of the murine CTSJ gene
was determined by typing the BSS interspeci¢c backcross pan-
el [(C57BL/6JEiUSPRET/Ei)F1USPRET/Ei] purchased from
The Jackson Laboratory [42]. A XbaI RFLP between M.
musculus C57BL/6J and M. spretus was detected with the
CTSJ cDNA (Fig. 4A). Segregation of the C57BL/6J-speci¢c
1.6 kb and 0.7 kb XbaI fragments was followed in 94 N2 mice.
Comparison of the distribution pattern of this Ctsj-speci¢c
RFLP with those for loci already located on the backcross
map [42] by minimizing mismatches resulted in localization of
mouse ctsj to chromosome 13, colocalizing with Fanconi ane-
mia (Facc [49]) and patched (Ptch [50] ; Fig. 4B,C). Mouse
Ctsl had been previously mapped to chromosome 13 in the
same area 4.0 þ 1.7 cM proximal of Facc [40,51,52]. These
¢ndings and the high degree of homology between CTSJ
and CTSL (Fig. 2; Table 1) suggest that CTSJ has evolved
from CTSL or a common ancestral gene by gene duplication.
Furthermore, the genes of the cytotoxic T-lymphocyte-associ-
ated proteins 2 alpha (Ctla-2K) and beta (Ctla-2L) map to the
Fig. 4. Chromosomal localization of mouse cathepsin J. A: XbaI RFLP between M. musculus C57BL/6J (B) and M. spretus (S) detected with
the full-length CTSJ cDNA. The segregation of the 1.6 kb and 0.7 kb C57BL/6J-speci¢c DNA fragments was followed. B: Segregation pattern
of Ctsj-speci¢c RFLP in 94 (C57BL/6JEiUSPRET/Ei)F1USPRET/Ei interspeci¢c backcross progeny. Loci linked to Ctsj are listed from proxi-
mal at the top to distal at the bottom. Each column represents a chromosomal haplotype, with the number of animals observed with each spe-
ci¢c haplotype given below. Animals were scored at each locus as heterozygous for the M. spretus and C57BL/6J alleles (¢lled boxes) or homo-
zygous for the M. spretus alleles (open boxes). C: Partial linkage map of mouse chromosome 13 depicting the position of Ctsj. The distances
between the loci are given to the left in cM. Ctsj has been con¢rmed as an approved locus name by the MGD Nomenclature Support Sta¡.
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same region of mouse chromosome 13 [53^55]. These proteins
of unknown function show high homologies to the proregion
of cathepsin L-like cysteine proteases suggesting at least one
additional partial gene duplication in this region of chromo-
some 13. These duplication events may have resulted in a
cluster of genes encoding cathepsin L-like proteases and re-
lated proteins such as CTLA-2K and CTLA-2L.
In conclusion,cathepsin J is a novel mammalian member of
the C1 family of cysteine proteases with tissue-speci¢c expres-
sion restricted to placenta. This may suggest physiological in
vivo functions in embryo implantation and/or placental func-
tion.
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